Economy Bloomberg 2h ago

Pharma Deals Aren't Just Based on Price: Eric Tokat

{# Share Buttons Partial Variables: share_title — text to pre-fill in share dialogs share_url — canonical URL to share (use request.build_absolute_uri in parent) #}

Market Intelligence Analysis

AI-Powered
Why This Matters

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.

Sentiment
Neutral
AI Confidence
94%
Time Horizon
Short Term

Article Context

Note: This is a brief excerpt for context. Click below to read the full article on the original source.

Eric Tokat, co-president of investment banking at Centerview Partners, and Krishna Veeraraghavan, global co-head of M&A at Paul Weiss, joins Dani Burger and Michelle Davis on "Bloomberg Deals." They discuss the best way to approach and invest in the pharma sector. (Source: Bloomberg)

Continue Reading
Full article on Bloomberg
Read Full Article

Related Articles

Economy 13m ago

Dow Jones Futures: Oil Prices Weigh On Stocks, But Oracle, Nvidia Lift …

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.
Economy 17m ago

Sealed Air $7 Billion Buyout Debt May Launch Next Week

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.
Economy 18m ago

Ariel's Phillpotts: EM Economies Are More Resilient

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.
Economy 29m ago

Apollo Ramps Up Efforts to Mark Private Credit Daily

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.
Economy 38m ago

SpaceX, OpenAI Potential Blockbuster IPOs Lure Investors Into Murky Deals

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.
Economy 52m ago

Citi's Sheets: May See Inflation Uptick in Coming Months

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.
Original article published by Bloomberg on March 11, 2026.
Analysis and insights provided by AnalystMarkets AI.